GEAC halt GM mustard cultivation
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 15 Feb, 2016
Genetic Engineering Appraisal Committee (GEAC), the regulatory body fo...Read more
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 13 Nov, 2013
With the aim to raise awareness for the growing incidence of Diabetes,...Read more
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 22 Mar, 2016
ARIAD Pharmaceuticals announced the appointment of Mr Manmeet Soni, 38...Read more
Novo Nordisk's Ryzodeg now available in India
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 20 Jan, 2015
Novo Nordisk has launched it's combination diabetic drug Ryzodeg for p...Read more
GM is a key part of technological intervention for food governance, agree experts
BioPharma | News | By Rahul Koul Koul | 0 Comment | 12 Nov, 2013
While advanced technologies can provide much of the solutions for impr...Read more
Ganymed's IMAB362 to bring hope to Gastric Cancer patients
BioPharma | Features | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2016
New data regarding Ganymed Pharmaceuticals' drug IMAB362, presented at...Read more
Technologies must reach end users : Tariq Anwar
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 14 Jun, 2013
During his recent visit to the National Institute of Animal Nutrition ...Read more
Monsanto researchers showcase new breakthrough in protein science
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2016
Research published today is poised to deliver never-before-seen breakt...Read more
Sanofi appoints Dr Ameet Nathwani as EVP
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 10 Mar, 2016
Dr Nathwani will be responsible for enterprise-wide medical, patient s...Read more
FDA approves Lupin's new generic
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 23 Jun, 2016
Pharma Major Lupin announced that its US subsidiary, Gavis Pharmaceuti...Read more
Roche's Tecentriq may dominate bladder cancer market
BioPharma | Features | By BioSpectrum Bureau | 0 Comment | 22 Jun, 2016
As explored in an abstract presented at the 2016 American Society of C...Read more
Pharmaceutical companies increasingly looking to innovate high-risk, first-in-class products
BioPharma | Features | By BioSpectrum Bureau | 0 Comment | 22 Jun, 2016
With the cost of bringing a single novel drug to market estimated to b...Read more
Biocon, Quark initiates study of QPI-1007 in rare eye disease
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 23 Jun, 2016
Biocon and Quark Pharmaceuticals,a leader in the discovery and develop...Read more
Patent applied for thalassemia through nutraceuticals
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2016
Thalassemia is a disorder of abnormal formation of hemoglobin and ther...Read more
Biolubricants market worth $3.15 bn by 2021
BioPharma | Features | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2016
According to a new market research report published by MarketsandMarke...Read more
Strides to acquire Shasun for $200 million
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2014
The resulting merger will generate revenues close to $406 million and ...Read more
New Vasculitis drug to address unmet needs
BioPharma | Features | By BioSpectrum Bureau | 0 Comment | 27 May, 2016
ChemoCentryx's CCX168, an orally administered small molecule in develo...Read more
Global cancer treatment market grew to $107 bn in 2015
BioPharma | Features | By BioSpectrum Bureau | 0 Comment | 23 Jun, 2016
More than 20 tumor types are being treated with one or more of the 70 ...Read more